Restrictive Lung Disease

Prophylactic Azithromycin Beneficial in Idiopathic Pulmonary Fibrosis

Prophylactic Azithromycin Beneficial in Idiopathic Pulmonary Fibrosis

By

Prophylactic azithromycin may reduce hospital stays and the need for rescue antibiotics in patients with idiopathic pulmonary fibrosis.

Hypersensitivity Pneumonitis Prognosis by Phenotype

Hypersensitivity Pneumonitis Prognosis by Phenotype

By

Compared with idiopathic pulmonary fibrosis, nonhoneycomb hypersensitivity pneumonitis phenotypes are associated with greater improvements in percent-predicted forced vital capacity.

High IL-18 Levels Associated With Interstitial Lung Disease in RA

High IL-18 Levels Associated With Interstitial Lung Disease in RA

By

Researchers investigated whether increased IL-18 levels were associated with interstitial lung disease in rheumatoid arthritis.

Measuring Physical Activity Levels in Fibrotic Interstitial Lung Disease

Measuring Physical Activity Levels in Fibrotic Interstitial Lung Disease

By

The International Physical Activity Questionnaire long form is considered valid and consistent for measuring levels of physical activity in patients with fibrotic interstitial lung disease.

Pirfenidone May Be Effective for Improving Exercise Capacity, Dyspnea in Idiopathic Pulmonary Fibrosis

Pirfenidone May Be Effective for Improving Exercise Capacity, Dyspnea in Idiopathic Pulmonary Fibrosis

By

When treated with pirfenidone, patients with idiopathic pulmonary fibrosis experienced significant improvements in 6-minute walking distance and University of California San Diego Shortness of Breath Questionnaire scores.

Trends in Sarcoidosis-Related Hospitalizations in the United States

Trends in Sarcoidosis-Related Hospitalizations in the United States

By

Blacks experience a significantly higher rate of sarcoidosis-associated hospitalizations compared with whites.

Ambulatory Oxygen Improves Interstitial Lung Disease Quality of Life

Ambulatory Oxygen Improves Interstitial Lung Disease Quality of Life

By

Health-related quality of life and isolated exertional hypoxia in patients with interstitial lung disease may be improved by the use of ambulatory oxygen.

Ofev Shown to Slow Idiopathic Pulmonary Fibrosis Progression Long-Term

Ofev Shown to Slow Idiopathic Pulmonary Fibrosis Progression Long-Term

By

The primary objective was to characterize the long-term safety and tolerability of Ofev in patients with IPF; efficacy endpoints included annual rate of decline in forced vital capacity (FVC) calculated over 192 weeks.

No Benefit From Nintedanib Plus Sildenafil in Idiopathic Pulmonary Fibrosis

No Benefit From Nintedanib Plus Sildenafil in Idiopathic Pulmonary Fibrosis

By

Nintedanib plus sildenafil did not improve St. George's Respiratory Questionnaire scores in patients with idiopathic pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis and GERD: An Unclear Connection

Idiopathic Pulmonary Fibrosis and GERD: An Unclear Connection

By

Although gastroesophageal reflux disease and idiopathic pulmonary fibrosis may be related, the association between the 2 disorders is most likely confounded by smoking.

FDA Fast-Tracks Pamrevlumab for Idiopathic Pulmonary Fibrosis

FDA Fast-Tracks Pamrevlumab for Idiopathic Pulmonary Fibrosis

By

The FDA's designation was based on data from a Phase 2 placebo-controlled trial that demonstrated pamrevlumab could potentially address an unmet medical need for this condition.

Laparoscopic Antireflux Surgery for Treating Idiopathic Pulmonary Fibrosis

Laparoscopic Antireflux Surgery for Treating Idiopathic Pulmonary Fibrosis

By

Laparoscopic antireflux surgery was safe and well tolerated in patients with idiopathic pulmonary fibrosis and abnormal acid gastroesophageal reflux.

Interstitial Lung Disease Diagnosis Improved Using Rheumatologic Assessment

Interstitial Lung Disease Diagnosis Improved Using Rheumatologic Assessment

By

Adding routine rheumatologic assessments to interstitial lung disease diagnosis could reduce the need for invasive procedures and improve diagnostic accuracy.

Rituximab Safe and Efficacious Alternative Treatment for Scleroderma

Rituximab Safe and Efficacious Alternative Treatment for Scleroderma

By

Rituximab is a safe and effective alternative to cyclophosphamide in managing the progression of scleroderma and subsequent development of interstitial lung disease.

Anti-Fibrotic Drug Gets Orphan Drug Status for Idiopathic Pulmonary Fibrosis

Anti-Fibrotic Drug Gets Orphan Drug Status for Idiopathic Pulmonary Fibrosis

By

Targeting TGF-β signaling in a tissue-specific manner allows the drug to modulate the fibrotic cascade with maximum clinical effects while avoiding adverse events.

Chronic Cough in Interstitial Lung Disease: More Clinical Trials Needed

Chronic Cough in Interstitial Lung Disease: More Clinical Trials Needed

By

An expert panel developed suggestions for chronic cough management in interstitial lung disease, but more clinical trials are needed to establish recommendations.

Nintedanib and Pirfenidone Tolerated in Idiopathic Pulmonary Fibrosis

Nintedanib and Pirfenidone Tolerated in Idiopathic Pulmonary Fibrosis

By

Many patients with idiopathic pulmonary fibrosis in an international phase 4 study tolerated combination therapy with pirfenidone and nintedanib.

Lung Transplant Survival Lower During Acute Exacerbations of IPF

Lung Transplant Survival Lower During Acute Exacerbations of IPF

By

Compared with individuals who had stable idiopathic pulmonary fibrosis, those with an acute exacerbation had a significantly shorter survival, especially at the 3 year follow-up.

Low Nailfold Capillary Density Associated With Lung Involvement in Juvenile Dermatomyositis

Low Nailfold Capillary Density Associated With Lung Involvement in Juvenile Dermatomyositis

By

Low nailfold capillary density is associated with impaired pulmonary function tests and more frequent high-resolution computed tomography abnormalities in patients with juvenile dermatomyositis.

Venoarterial ECMO Improves Survival to Transplant in Interstitial Lung Disease

Venoarterial ECMO Improves Survival to Transplant in Interstitial Lung Disease

In patients with end-stage interstitial lung disease, there was a higher rate of survival to transplantation with venoarterial extracorporeal membrane oxygenation.

Double Lung Transplantation Improves Survival in Interstitial Pulmonary Fibrosis

Double Lung Transplantation Improves Survival in Interstitial Pulmonary Fibrosis

Double lung transplantation appears to offer superior survival outcomes to single lung transplantation in patients with interstitial pulmonary fibrosis who are younger than 70 years.

Recombinant Human Pentraxin 2 Slowed Lung Function Decline in IPF

Recombinant Human Pentraxin 2 Slowed Lung Function Decline in IPF

By

Recombinant human pentraxin 2 therapy resulted in a slower decline in lung function in patients with idiopathic pulmonary fibrosis.

Sarcoidosis Diagnostic Score Enhances Disease Diagnosis

Sarcoidosis Diagnostic Score Enhances Disease Diagnosis

By

A Sarcoidosis Diagnostic Score tool was developed by comparing data from individuals with biopsy-confirmed sarcoidosis with that of individuals who did not have sarcoidosis.

Migraine a Common Comorbidity in Individuals With Sarcoidosis

Migraine a Common Comorbidity in Individuals With Sarcoidosis

The frequency of migraine and sarcoidosis comorbidity was examined in a cohort study.

Expert Consensus on Chronic Hypersensitivity Pneumonitis Diagnostic Criteria

Expert Consensus on Chronic Hypersensitivity Pneumonitis Diagnostic Criteria

By

Experts in interstitial lung disease identified 18 items of importance for diagnosing chronic hypersensitivity pneumonitis.

Idiopathic Pulmonary Fibrosis Outcomes Improved by Gastroesophageal Reflux Treatment

Idiopathic Pulmonary Fibrosis Outcomes Improved by Gastroesophageal Reflux Treatment

By

Treatment for gastroesophageal reflux significantly reduced mortality in idiopathic pulmonary fibrosis and improved transplant-free survival.

Predictors Identified for Myositis-Related Interstitial Lung Disease Mortality

Predictors Identified for Myositis-Related Interstitial Lung Disease Mortality

Researchers identified independent predictors of short-term dermatomyositis- or polymyositis-related interstitial lung disease mortality.

Treatment for Idiopathic Pulmonary Fibrosis Gets Orphan Drug Designation

Treatment for Idiopathic Pulmonary Fibrosis Gets Orphan Drug Designation

By

RP5063 is a new chemical entity with a novel mechanism of multimodal modulation of serotonin and dopamine signaling pathways.

Idiopathic Pulmonary Fibrosis in Dentists May Be Linked to Occupational Exposure

Idiopathic Pulmonary Fibrosis in Dentists May Be Linked to Occupational Exposure

By

Several patients were treated for idiopathic pulmonary fibrosis were identified as dental personnel.

A 67-Year-Old Woman With Hypertension, Diabetes Presents With Shortness of Breath

A 67-Year-Old Woman With Hypertension, Diabetes Presents With Shortness of Breath

By

After being treated for pyelonephritis and discharged to a nursing facility, a 67-year-old woman presents to the emergency department with shortness of breath.

Sign Up for Free e-newsletters